October 25, 2017
A newly announced study backed by Takeda Pharmaceuticals, Lundbeck US, and Advocate Health Care will explore the effectiveness of a mobile app designed to improve engagement between patients with major depressive disorder (MDD) and their providers.
The investigation will use the Advocate Pathway App to capture the start of or any adjustments to a patient’s antidepressant therapy. Through a...
August 3, 2017
Cloud-based healthcare services company PrescribeWellness is working with Coopharma, a Puerto Rican cooperative of community pharmacies. With PrescribeWellness’s offering, Coopharma will aim to increase medication adherence, patient loyalty and health.
“This partnership benefits our member pharmacies and all of their patients,” Heriberto Ortiz Martinez, executive director of Coopharma, said in a...
August 2, 2017
Personal genetics company 23andMe will be teaming up with the Milken Institute, a think tank, and pharmaceutical company Lundbeck to drive enrollment for a genetic study designed to grasp the underlying biology of major depressive and bipolar disorders.
The study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes -- such as...